TMDX — TransMedics Cashflow Statement
0.000.00%
Last trade - 00:00- $3.16bn
- $3.34bn
- $441.54m
- 78
- 13
- 72
- 54
Annual cashflow statement for TransMedics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.7 | -44.2 | -36.2 | -25 | 35.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.49 | 10.5 | 13.7 | 49.8 | 38.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.59 | 3 | -26.8 | -44.3 | -45 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -30.3 | -28.9 | -45.8 | -13 | 48.8 |
| Capital Expenditures | -0.455 | -3.52 | -11.9 | -152 | -130 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -41.1 | 32.8 | 66.4 | -42.1 | 0.441 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -41.6 | 29.3 | 54.5 | -194 | -129 |
| Financing Cash Flow Items | -0.705 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 75.5 | 1.39 | 168 | 400 | 22.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.49 | 0.999 | 176 | 194 | -58.2 |